scholarly journals Decreased Opioid Consumption and Durable Pain Relief in Patients Treated with 10 kHz SCS: A Retrospective Analysis of Outcomes from Single-Center

2021 ◽  
Vol Volume 14 ◽  
pp. 2593-2600
Author(s):  
Honghui Feng ◽  
Patrick Doherty ◽  
Anand Rotte
Keyword(s):  
Pain Relief ◽  
Retrospective Analysis ◽  
Opioid Consumption ◽  
Single Center

Single‐Center Retrospective Analysis of Device‐Related Complications Related to Dorsal Root Ganglion Stimulation for Pain Relief in 31 Patients

2021 ◽  
Author(s):  
Kevin Hines ◽  
Vishal Swaminathan ◽  
Sara Thalheimer ◽  
Michael Kogan ◽  
Chengyuan Wu ◽  
...  
Keyword(s):  
Pain Relief ◽  
Dorsal Root Ganglion ◽  
Retrospective Analysis ◽  
Dorsal Root ◽  
Single Center

A Retrospective Analysis of Oral Mucosa Pathologies: A Single-Center Trial

2018 ◽  
Vol 1 (34) ◽  
pp. 11-17
Author(s):  
hilal erinanç ◽  
özgül topal
Keyword(s):  
Retrospective Analysis ◽  
Oral Mucosa ◽  
Single Center

Retrospective analysis on the effect of spinal cord stimulation on opioid consumption

2020 ◽  
Author(s):  
Awinita Barpujari ◽  
Michael A Erdek
Keyword(s):  
Spinal Cord ◽  
Chronic Pain ◽  
Retrospective Analysis ◽  
Spinal Cord Stimulation ◽  
Alternative Therapy ◽  
Opioid Consumption ◽  
Opioid Use ◽  
Number Of Patients ◽  
Chronic Pain Conditions ◽  
Post Trial

Aim: Spinal cord stimulation (SCS) is used to clinically manage and/or treat several chronic pain etiologies. A limited amount is known about the influence on patients' use of opioid pain medication. This retrospective analysis evaluated SCS effect on opioid consumption in patients presenting with chronic pain conditions. Materials & methods: Sixty-seven patients underwent a temporary trial device, permanent implant or both. Patients were divided for assessment based on the nature of their procedure(s). Primary outcome was change in morphine equivalent dose (MED), ascertained from preoperative and postoperative medication reports. Results: Postoperative MED was significantly lower in patients who received some form of neuromodulation therapy. Pretrial patients reported an average MED of 41.01 ± 10.23 mg per day while post-trial patients reported an average of 13.30 ± 5.34 mg per day (p < 0.001). Pre-implant patients reported an average MED of 39.14 ± 13.52 mg per day while post-implant patients reported an average MED of 20.23 ± 9.01 mg per day (p < 0.001). There were no significant differences between pre-trial and pre-implant MED, nor between post-trial and post-implant MED. Of the 42 study subjects who reported some amount of pre-intervention opioid use, 78.57% indicated a lower MED (n = 33; p < 0.001), 16.67% indicated no change (n = 7) and 4.76% (n = 2) indicated a higher MED, following intervention. Moreover, SCS therapy resulted in a 26.83% reduction (p < 0.001) in the number of patients with MED >50 mg per day. Conclusion: Spinal cord stimulation may reduce opioid use when implemented appropriately. Neuromodulation may represent alternative therapy for alleviating chronic pain which may avoid a number of deleterious side effects commonly associated with opioid consumption.

Description of the role of pharmacist independent double checks during cognitive order verification of outpatient parenteral anti-cancer therapy

2021 ◽  
pp. 107815522199431
Author(s):  
Jennifer P Booth ◽  
Julie M Kennerly-Shah ◽  
Amber D Hartman
Keyword(s):  
Cancer Therapy ◽  
Medication Error ◽  
Retrospective Analysis ◽  
Error Reporting ◽  
Single Center ◽  
Medication Error Reporting ◽  
Anti Cancer ◽  
Secondary Endpoints ◽  
Type Frequency

Introduction To describe pharmacist interventions as a result of an independent double check during cognitive order verification of outpatient parenteral anti-cancer therapy. Methods A single-center, retrospective analysis of all individual orders for outpatient, parenteral anti-cancer agents within a hematology/oncology infusion center during a 30 day period was conducted. The primary endpoint was error identification rates during first and second verification. Secondary endpoints included the type, frequency, and severity of errors identified during second verification using a modified National Coordinating Council for Medication Error Reporting and Prevention Index. Results A total of 1970 anti-cancer parenteral orders were screened, from which 1645 received an independent double check and were included. The number of errors identified during first and second verification were 30 (1.8%) and 10 (0.6%) respectively; second verification resulted in a 33.3% increase in corrected errors. The 10 errors identified during second verification included: four rate transcriptions to optimize pump interoperability, three rate and/or volume modifications, two dosage adjustments, and one treatment deferral due to toxicity. The severity was classified as Category A for four (40%), Category C for three (30%), and Category D for three (30%) errors. This correlated to a low capacity for harm for seven (70%) and a serious capacity for three (30%) errors. Conclusions Second verification of outpatient, parenteral anti-cancer medication orders resulted in a 33.3% increase in corrected errors. Three errors detected during second verification were determined to have a serious capacity for harm, supporting the value of independent double checks during pharmacist cognitive order verification.

scholarly journals Prolonged Lenalidomide Therapy Does Not Impact Autologous PBSC Mobilization and Collection in Multiple Myeloma Patients: A Single Center Retrospective Analysis

2021 ◽  
Author(s):  
Andrew J. Cowan ◽  
Philip A. Stevenson ◽  
Damian J. Green ◽  
Sherilyn Tuazon ◽  
Edward N. Libby ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Retrospective Analysis ◽  
Single Center ◽  
Pbsc Mobilization

Pulmonary alveolar proteinosis: A single center retrospective analysis of 14 cases

2020 ◽  
Author(s):  
Ning Zhang ◽  
Zhilong Jiang ◽  
Changzhou Shao
Keyword(s):  
Retrospective Analysis ◽  
Pulmonary Alveolar Proteinosis ◽  
Single Center ◽  
Alveolar Proteinosis

Comment on: retrospective analysis of 95 patients with large vessel vasculitis: a single center experience

2016 ◽  
Vol 20 (12) ◽  
pp. 2211-2213 ◽  
Author(s):  
Natsuki Shima ◽  
Takao Nagashima ◽  
Masahiro Iwamoto ◽  
Seiji Minota
Keyword(s):  
Retrospective Analysis ◽  
Large Vessel Vasculitis ◽  
Large Vessel ◽  
Single Center ◽  
Single Center Experience
Sign in / Sign up

Export Citation Format

Share Document